Global Oncology/Cancer Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Oncology/Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncology/Cancer Drugs market size is estimated to be worth US$ 96320 million in 2021 and is forecast to a readjusted size of USD 127740 million by 2028 with a CAGR of 4.1% during review period. Blood Cancer accounting for % of the Oncology/Cancer Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antimetabolite segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology/Cancer Drugs include Roche, HENGRUI, AstraZeneca, QILU, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology/Cancer Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Oncology/Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology/Cancer Drugs, with price, sales, revenue and global market share of Oncology/Cancer Drugs from 2019 to 2022.
Chapter 3, the Oncology/Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology/Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology/Cancer Drugs.
Chapter 13, 14, and 15, to describe Oncology/Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncology/Cancer Drugs market size is estimated to be worth US$ 96320 million in 2021 and is forecast to a readjusted size of USD 127740 million by 2028 with a CAGR of 4.1% during review period. Blood Cancer accounting for % of the Oncology/Cancer Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antimetabolite segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology/Cancer Drugs include Roche, HENGRUI, AstraZeneca, QILU, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology/Cancer Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Antimetabolite
- Alkaloid drugs
- Hormone
- Targeted drug
- Platinum-based drugs
- Other
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other
- Roche
- HENGRUI
- AstraZeneca
- QILU
- Sanofi
- HANSOH
- LUYE
- Novartis
- GuiZhou YiBai
- Lunan
- Eli Lilly and Company
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oncology/Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology/Cancer Drugs, with price, sales, revenue and global market share of Oncology/Cancer Drugs from 2019 to 2022.
Chapter 3, the Oncology/Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology/Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology/Cancer Drugs.
Chapter 13, 14, and 15, to describe Oncology/Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Oncology/Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology/Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antimetabolite
1.2.3 Alkaloid drugs
1.2.4 Hormone
1.2.5 Targeted drug
1.2.6 Platinum-based drugs
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology/Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other
1.4 Global Oncology/Cancer Drugs Market Size & Forecast
1.4.1 Global Oncology/Cancer Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology/Cancer Drugs Sales in Volume (2017-2028)
1.4.3 Global Oncology/Cancer Drugs Price (2017-2028)
1.5 Global Oncology/Cancer Drugs Production Capacity Analysis
1.5.1 Global Oncology/Cancer Drugs Total Production Capacity (2017-2028)
1.5.2 Global Oncology/Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology/Cancer Drugs Market Drivers
1.6.2 Oncology/Cancer Drugs Market Restraints
1.6.3 Oncology/Cancer Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology/Cancer Drugs Product and Services
2.1.4 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 HENGRUI
2.2.1 HENGRUI Details
2.2.2 HENGRUI Major Business
2.2.3 HENGRUI Oncology/Cancer Drugs Product and Services
2.2.4 HENGRUI Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Oncology/Cancer Drugs Product and Services
2.3.4 AstraZeneca Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 QILU
2.4.1 QILU Details
2.4.2 QILU Major Business
2.4.3 QILU Oncology/Cancer Drugs Product and Services
2.4.4 QILU Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Oncology/Cancer Drugs Product and Services
2.5.4 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HANSOH
2.6.1 HANSOH Details
2.6.2 HANSOH Major Business
2.6.3 HANSOH Oncology/Cancer Drugs Product and Services
2.6.4 HANSOH Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 LUYE
2.7.1 LUYE Details
2.7.2 LUYE Major Business
2.7.3 LUYE Oncology/Cancer Drugs Product and Services
2.7.4 LUYE Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Oncology/Cancer Drugs Product and Services
2.8.4 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GuiZhou YiBai
2.9.1 GuiZhou YiBai Details
2.9.2 GuiZhou YiBai Major Business
2.9.3 GuiZhou YiBai Oncology/Cancer Drugs Product and Services
2.9.4 GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lunan
2.10.1 Lunan Details
2.10.2 Lunan Major Business
2.10.3 Lunan Oncology/Cancer Drugs Product and Services
2.10.4 Lunan Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly and Company
2.11.1 Eli Lilly and Company Details
2.11.2 Eli Lilly and Company Major Business
2.11.3 Eli Lilly and Company Oncology/Cancer Drugs Product and Services
2.11.4 Eli Lilly and Company Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 ONCOLOGY/CANCER DRUGS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Oncology/Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology/Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology/Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2021
3.5 Global Oncology/Cancer Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology/Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Oncology/Cancer Drugs Market Size by Region
4.1.1 Global Oncology/Cancer Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology/Cancer Drugs Revenue by Region (2017-2028)
4.2 North America Oncology/Cancer Drugs Revenue (2017-2028)
4.3 Europe Oncology/Cancer Drugs Revenue (2017-2028)
4.4 Asia-Pacific Oncology/Cancer Drugs Revenue (2017-2028)
4.5 South America Oncology/Cancer Drugs Revenue (2017-2028)
4.6 Middle East and Africa Oncology/Cancer Drugs Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncology/Cancer Drugs Sales in Volume by Type (2017-2028)
5.2 Global Oncology/Cancer Drugs Revenue by Type (2017-2028)
5.3 Global Oncology/Cancer Drugs Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncology/Cancer Drugs Sales in Volume by Application (2017-2028)
6.2 Global Oncology/Cancer Drugs Revenue by Application (2017-2028)
6.3 Global Oncology/Cancer Drugs Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Oncology/Cancer Drugs Sales by Type (2017-2028)
7.2 North America Oncology/Cancer Drugs Sales by Application (2017-2028)
7.3 North America Oncology/Cancer Drugs Market Size by Country
7.3.1 North America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology/Cancer Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Oncology/Cancer Drugs Sales by Type (2017-2028)
8.2 Europe Oncology/Cancer Drugs Sales by Application (2017-2028)
8.3 Europe Oncology/Cancer Drugs Market Size by Country
8.3.1 Europe Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology/Cancer Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Oncology/Cancer Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology/Cancer Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology/Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology/Cancer Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Oncology/Cancer Drugs Sales by Type (2017-2028)
10.2 South America Oncology/Cancer Drugs Sales by Application (2017-2028)
10.3 South America Oncology/Cancer Drugs Market Size by Country
10.3.1 South America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology/Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology/Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Oncology/Cancer Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology/Cancer Drugs
12.3 Oncology/Cancer Drugs Production Process
12.4 Oncology/Cancer Drugs Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology/Cancer Drugs Typical Distributors
13.3 Oncology/Cancer Drugs Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Oncology/Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology/Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antimetabolite
1.2.3 Alkaloid drugs
1.2.4 Hormone
1.2.5 Targeted drug
1.2.6 Platinum-based drugs
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology/Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other
1.4 Global Oncology/Cancer Drugs Market Size & Forecast
1.4.1 Global Oncology/Cancer Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology/Cancer Drugs Sales in Volume (2017-2028)
1.4.3 Global Oncology/Cancer Drugs Price (2017-2028)
1.5 Global Oncology/Cancer Drugs Production Capacity Analysis
1.5.1 Global Oncology/Cancer Drugs Total Production Capacity (2017-2028)
1.5.2 Global Oncology/Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology/Cancer Drugs Market Drivers
1.6.2 Oncology/Cancer Drugs Market Restraints
1.6.3 Oncology/Cancer Drugs Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology/Cancer Drugs Product and Services
2.1.4 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 HENGRUI
2.2.1 HENGRUI Details
2.2.2 HENGRUI Major Business
2.2.3 HENGRUI Oncology/Cancer Drugs Product and Services
2.2.4 HENGRUI Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Oncology/Cancer Drugs Product and Services
2.3.4 AstraZeneca Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 QILU
2.4.1 QILU Details
2.4.2 QILU Major Business
2.4.3 QILU Oncology/Cancer Drugs Product and Services
2.4.4 QILU Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Oncology/Cancer Drugs Product and Services
2.5.4 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HANSOH
2.6.1 HANSOH Details
2.6.2 HANSOH Major Business
2.6.3 HANSOH Oncology/Cancer Drugs Product and Services
2.6.4 HANSOH Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 LUYE
2.7.1 LUYE Details
2.7.2 LUYE Major Business
2.7.3 LUYE Oncology/Cancer Drugs Product and Services
2.7.4 LUYE Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Oncology/Cancer Drugs Product and Services
2.8.4 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GuiZhou YiBai
2.9.1 GuiZhou YiBai Details
2.9.2 GuiZhou YiBai Major Business
2.9.3 GuiZhou YiBai Oncology/Cancer Drugs Product and Services
2.9.4 GuiZhou YiBai Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lunan
2.10.1 Lunan Details
2.10.2 Lunan Major Business
2.10.3 Lunan Oncology/Cancer Drugs Product and Services
2.10.4 Lunan Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly and Company
2.11.1 Eli Lilly and Company Details
2.11.2 Eli Lilly and Company Major Business
2.11.3 Eli Lilly and Company Oncology/Cancer Drugs Product and Services
2.11.4 Eli Lilly and Company Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 ONCOLOGY/CANCER DRUGS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Oncology/Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology/Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology/Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2021
3.5 Global Oncology/Cancer Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology/Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Oncology/Cancer Drugs Market Size by Region
4.1.1 Global Oncology/Cancer Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology/Cancer Drugs Revenue by Region (2017-2028)
4.2 North America Oncology/Cancer Drugs Revenue (2017-2028)
4.3 Europe Oncology/Cancer Drugs Revenue (2017-2028)
4.4 Asia-Pacific Oncology/Cancer Drugs Revenue (2017-2028)
4.5 South America Oncology/Cancer Drugs Revenue (2017-2028)
4.6 Middle East and Africa Oncology/Cancer Drugs Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncology/Cancer Drugs Sales in Volume by Type (2017-2028)
5.2 Global Oncology/Cancer Drugs Revenue by Type (2017-2028)
5.3 Global Oncology/Cancer Drugs Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncology/Cancer Drugs Sales in Volume by Application (2017-2028)
6.2 Global Oncology/Cancer Drugs Revenue by Application (2017-2028)
6.3 Global Oncology/Cancer Drugs Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Oncology/Cancer Drugs Sales by Type (2017-2028)
7.2 North America Oncology/Cancer Drugs Sales by Application (2017-2028)
7.3 North America Oncology/Cancer Drugs Market Size by Country
7.3.1 North America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology/Cancer Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Oncology/Cancer Drugs Sales by Type (2017-2028)
8.2 Europe Oncology/Cancer Drugs Sales by Application (2017-2028)
8.3 Europe Oncology/Cancer Drugs Market Size by Country
8.3.1 Europe Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology/Cancer Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Oncology/Cancer Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology/Cancer Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology/Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology/Cancer Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Oncology/Cancer Drugs Sales by Type (2017-2028)
10.2 South America Oncology/Cancer Drugs Sales by Application (2017-2028)
10.3 South America Oncology/Cancer Drugs Market Size by Country
10.3.1 South America Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology/Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology/Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology/Cancer Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology/Cancer Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Oncology/Cancer Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology/Cancer Drugs
12.3 Oncology/Cancer Drugs Production Process
12.4 Oncology/Cancer Drugs Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology/Cancer Drugs Typical Distributors
13.3 Oncology/Cancer Drugs Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncology/Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oncology/Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology/Cancer Drugs Product and Services
Table 6. Roche Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. HENGRUI Basic Information, Manufacturing Base and Competitors
Table 8. HENGRUI Major Business
Table 9. HENGRUI Oncology/Cancer Drugs Product and Services
Table 10. HENGRUI Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Oncology/Cancer Drugs Product and Services
Table 14. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. QILU Basic Information, Manufacturing Base and Competitors
Table 16. QILU Major Business
Table 17. QILU Oncology/Cancer Drugs Product and Services
Table 18. QILU Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Oncology/Cancer Drugs Product and Services
Table 22. Sanofi Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HANSOH Basic Information, Manufacturing Base and Competitors
Table 24. HANSOH Major Business
Table 25. HANSOH Oncology/Cancer Drugs Product and Services
Table 26. HANSOH Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. LUYE Basic Information, Manufacturing Base and Competitors
Table 28. LUYE Major Business
Table 29. LUYE Oncology/Cancer Drugs Product and Services
Table 30. LUYE Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Oncology/Cancer Drugs Product and Services
Table 34. Novartis Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GuiZhou YiBai Basic Information, Manufacturing Base and Competitors
Table 36. GuiZhou YiBai Major Business
Table 37. GuiZhou YiBai Oncology/Cancer Drugs Product and Services
Table 38. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lunan Basic Information, Manufacturing Base and Competitors
Table 40. Lunan Major Business
Table 41. Lunan Oncology/Cancer Drugs Product and Services
Table 42. Lunan Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly and Company Major Business
Table 45. Eli Lilly and Company Oncology/Cancer Drugs Product and Services
Table 46. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Oncology/Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 48. Global Oncology/Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Oncology/Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Oncology/Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Oncology/Cancer Drugs Production Site of Key Manufacturer
Table 52. Oncology/Cancer Drugs New Entrant and Capacity Expansion Plans
Table 53. Oncology/Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 55. Global Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 56. Global Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 59. Global Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 60. Global Oncology/Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Oncology/Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Oncology/Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 63. Global Oncology/Cancer Drugs Price by Type (2023-2028) & (USD/MT)
Table 64. Global Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 65. Global Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 66. Global Oncology/Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Oncology/Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Oncology/Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 69. Global Oncology/Cancer Drugs Price by Application (2023-2028) & (USD/MT)
Table 70. North America Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 71. North America Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 72. North America Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 75. North America Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 76. North America Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 77. North America Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Europe Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 79. Europe Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 80. Europe Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 83. Europe Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 84. Europe Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 85. Europe Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 86. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 87. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 88. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 91. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 92. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 93. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 94. South America Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 95. South America Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 96. South America Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 99. South America Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 100. South America Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 101. South America Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 102. Middle East & Africa Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 103. Middle East & Africa Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 104. Middle East & Africa Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 107. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 108. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 109. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 110. Oncology/Cancer Drugs Raw Material
Table 111. Key Manufacturers of Oncology/Cancer Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Oncology/Cancer Drugs Typical Distributors
Table 115. Oncology/Cancer Drugs Typical Customers
Table 1. Global Oncology/Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oncology/Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology/Cancer Drugs Product and Services
Table 6. Roche Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. HENGRUI Basic Information, Manufacturing Base and Competitors
Table 8. HENGRUI Major Business
Table 9. HENGRUI Oncology/Cancer Drugs Product and Services
Table 10. HENGRUI Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Oncology/Cancer Drugs Product and Services
Table 14. AstraZeneca Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. QILU Basic Information, Manufacturing Base and Competitors
Table 16. QILU Major Business
Table 17. QILU Oncology/Cancer Drugs Product and Services
Table 18. QILU Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Oncology/Cancer Drugs Product and Services
Table 22. Sanofi Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HANSOH Basic Information, Manufacturing Base and Competitors
Table 24. HANSOH Major Business
Table 25. HANSOH Oncology/Cancer Drugs Product and Services
Table 26. HANSOH Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. LUYE Basic Information, Manufacturing Base and Competitors
Table 28. LUYE Major Business
Table 29. LUYE Oncology/Cancer Drugs Product and Services
Table 30. LUYE Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Oncology/Cancer Drugs Product and Services
Table 34. Novartis Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GuiZhou YiBai Basic Information, Manufacturing Base and Competitors
Table 36. GuiZhou YiBai Major Business
Table 37. GuiZhou YiBai Oncology/Cancer Drugs Product and Services
Table 38. GuiZhou YiBai Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lunan Basic Information, Manufacturing Base and Competitors
Table 40. Lunan Major Business
Table 41. Lunan Oncology/Cancer Drugs Product and Services
Table 42. Lunan Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly and Company Major Business
Table 45. Eli Lilly and Company Oncology/Cancer Drugs Product and Services
Table 46. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Oncology/Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 48. Global Oncology/Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Oncology/Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Oncology/Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Oncology/Cancer Drugs Production Site of Key Manufacturer
Table 52. Oncology/Cancer Drugs New Entrant and Capacity Expansion Plans
Table 53. Oncology/Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 55. Global Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 56. Global Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 59. Global Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 60. Global Oncology/Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Oncology/Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Oncology/Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 63. Global Oncology/Cancer Drugs Price by Type (2023-2028) & (USD/MT)
Table 64. Global Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 65. Global Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 66. Global Oncology/Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Oncology/Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Oncology/Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 69. Global Oncology/Cancer Drugs Price by Application (2023-2028) & (USD/MT)
Table 70. North America Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 71. North America Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 72. North America Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 75. North America Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 76. North America Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 77. North America Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Europe Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 79. Europe Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 80. Europe Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 83. Europe Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 84. Europe Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 85. Europe Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 86. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 87. Asia-Pacific Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 88. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 91. Asia-Pacific Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 92. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 93. Asia-Pacific Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 94. South America Oncology/Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 95. South America Oncology/Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 96. South America Oncology/Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Oncology/Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 99. South America Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 100. South America Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 101. South America Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 102. Middle East & Africa Oncology/Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 103. Middle East & Africa Oncology/Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 104. Middle East & Africa Oncology/Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Oncology/Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 107. Middle East & Africa Oncology/Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 108. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 109. Middle East & Africa Oncology/Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 110. Oncology/Cancer Drugs Raw Material
Table 111. Key Manufacturers of Oncology/Cancer Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Oncology/Cancer Drugs Typical Distributors
Table 115. Oncology/Cancer Drugs Typical Customers
LIST OF FIGURES
Figure 1. Oncology/Cancer Drugs Picture
Figure 2. Global Oncology/Cancer Drugs Revenue Market Share by Type in 2021
Figure 3. Antimetabolite
Figure 4. Alkaloid drugs
Figure 5. Hormone
Figure 6. Targeted drug
Figure 7. Platinum-based drugs
Figure 8. Other
Figure 9. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2021
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Global Oncology/Cancer Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 17. Global Oncology/Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Oncology/Cancer Drugs Sales (2017-2028) & (K MT)
Figure 19. Global Oncology/Cancer Drugs Price (2017-2028) & (USD/MT)
Figure 20. Global Oncology/Cancer Drugs Production Capacity (2017-2028) & (K MT)
Figure 21. Global Oncology/Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Oncology/Cancer Drugs Market Drivers
Figure 23. Oncology/Cancer Drugs Market Restraints
Figure 24. Oncology/Cancer Drugs Market Trends
Figure 25. Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Oncology/Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 40. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Oncology/Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Oncology/Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 43. North America Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs in 2021
Figure 84. Manufacturing Process Analysis of Oncology/Cancer Drugs
Figure 85. Oncology/Cancer Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Oncology/Cancer Drugs Picture
Figure 2. Global Oncology/Cancer Drugs Revenue Market Share by Type in 2021
Figure 3. Antimetabolite
Figure 4. Alkaloid drugs
Figure 5. Hormone
Figure 6. Targeted drug
Figure 7. Platinum-based drugs
Figure 8. Other
Figure 9. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2021
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Global Oncology/Cancer Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 17. Global Oncology/Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Oncology/Cancer Drugs Sales (2017-2028) & (K MT)
Figure 19. Global Oncology/Cancer Drugs Price (2017-2028) & (USD/MT)
Figure 20. Global Oncology/Cancer Drugs Production Capacity (2017-2028) & (K MT)
Figure 21. Global Oncology/Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Oncology/Cancer Drugs Market Drivers
Figure 23. Oncology/Cancer Drugs Market Restraints
Figure 24. Oncology/Cancer Drugs Market Trends
Figure 25. Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Oncology/Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Oncology/Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Oncology/Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 40. Global Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Oncology/Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Oncology/Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 43. North America Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Oncology/Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Oncology/Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Oncology/Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Oncology/Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Oncology/Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs in 2021
Figure 84. Manufacturing Process Analysis of Oncology/Cancer Drugs
Figure 85. Oncology/Cancer Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
